THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS

The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SÁNCHEZ-QUESADA, Jorge, MEDINA PADILLA, Miguel, DE CRISTOBAL BLANCO, Javier, PALOMO NICOLAU, Francisco, PÉREZ DE LA CRUZ MORENO, María Ángeles, MARTÍNEZ MONTERO, Olga, HERRERO SANTOS, Susana, RODRÍGUEZ SALGUERO, Beatriz, DOMÍNGUEZ CORREA, Juan Manuel, FUERTES HUERTA, Ana, LÓPEZ OGALLA, Javier
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SÁNCHEZ-QUESADA, Jorge
MEDINA PADILLA, Miguel
DE CRISTOBAL BLANCO, Javier
PALOMO NICOLAU, Francisco
PÉREZ DE LA CRUZ MORENO, María Ángeles
MARTÍNEZ MONTERO, Olga
HERRERO SANTOS, Susana
RODRÍGUEZ SALGUERO, Beatriz
DOMÍNGUEZ CORREA, Juan Manuel
FUERTES HUERTA, Ana
LÓPEZ OGALLA, Javier
description The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2017248556BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2017248556BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2017248556BB23</originalsourceid><addsrcrecordid>eNrjZNAM8fB0dPF0jPL38XTx9HN18fT3cw1WcAxWcA_21jVW8PTz8HTyDPEPCuZhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhuZGJhampmZOTkbGRCoDAAfuJcI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><source>esp@cenet</source><creator>SÁNCHEZ-QUESADA, Jorge ; MEDINA PADILLA, Miguel ; DE CRISTOBAL BLANCO, Javier ; PALOMO NICOLAU, Francisco ; PÉREZ DE LA CRUZ MORENO, María Ángeles ; MARTÍNEZ MONTERO, Olga ; HERRERO SANTOS, Susana ; RODRÍGUEZ SALGUERO, Beatriz ; DOMÍNGUEZ CORREA, Juan Manuel ; FUERTES HUERTA, Ana ; LÓPEZ OGALLA, Javier</creator><creatorcontrib>SÁNCHEZ-QUESADA, Jorge ; MEDINA PADILLA, Miguel ; DE CRISTOBAL BLANCO, Javier ; PALOMO NICOLAU, Francisco ; PÉREZ DE LA CRUZ MORENO, María Ángeles ; MARTÍNEZ MONTERO, Olga ; HERRERO SANTOS, Susana ; RODRÍGUEZ SALGUERO, Beatriz ; DOMÍNGUEZ CORREA, Juan Manuel ; FUERTES HUERTA, Ana ; LÓPEZ OGALLA, Javier</creatorcontrib><description>The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180809&amp;DB=EPODOC&amp;CC=AU&amp;NR=2017248556B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180809&amp;DB=EPODOC&amp;CC=AU&amp;NR=2017248556B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SÁNCHEZ-QUESADA, Jorge</creatorcontrib><creatorcontrib>MEDINA PADILLA, Miguel</creatorcontrib><creatorcontrib>DE CRISTOBAL BLANCO, Javier</creatorcontrib><creatorcontrib>PALOMO NICOLAU, Francisco</creatorcontrib><creatorcontrib>PÉREZ DE LA CRUZ MORENO, María Ángeles</creatorcontrib><creatorcontrib>MARTÍNEZ MONTERO, Olga</creatorcontrib><creatorcontrib>HERRERO SANTOS, Susana</creatorcontrib><creatorcontrib>RODRÍGUEZ SALGUERO, Beatriz</creatorcontrib><creatorcontrib>DOMÍNGUEZ CORREA, Juan Manuel</creatorcontrib><creatorcontrib>FUERTES HUERTA, Ana</creatorcontrib><creatorcontrib>LÓPEZ OGALLA, Javier</creatorcontrib><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><description>The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAM8fB0dPF0jPL38XTx9HN18fT3cw1WcAxWcA_21jVW8PTz8HTyDPEPCuZhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhuZGJhampmZOTkbGRCoDAAfuJcI</recordid><startdate>20180809</startdate><enddate>20180809</enddate><creator>SÁNCHEZ-QUESADA, Jorge</creator><creator>MEDINA PADILLA, Miguel</creator><creator>DE CRISTOBAL BLANCO, Javier</creator><creator>PALOMO NICOLAU, Francisco</creator><creator>PÉREZ DE LA CRUZ MORENO, María Ángeles</creator><creator>MARTÍNEZ MONTERO, Olga</creator><creator>HERRERO SANTOS, Susana</creator><creator>RODRÍGUEZ SALGUERO, Beatriz</creator><creator>DOMÍNGUEZ CORREA, Juan Manuel</creator><creator>FUERTES HUERTA, Ana</creator><creator>LÓPEZ OGALLA, Javier</creator><scope>EVB</scope></search><sort><creationdate>20180809</creationdate><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><author>SÁNCHEZ-QUESADA, Jorge ; MEDINA PADILLA, Miguel ; DE CRISTOBAL BLANCO, Javier ; PALOMO NICOLAU, Francisco ; PÉREZ DE LA CRUZ MORENO, María Ángeles ; MARTÍNEZ MONTERO, Olga ; HERRERO SANTOS, Susana ; RODRÍGUEZ SALGUERO, Beatriz ; DOMÍNGUEZ CORREA, Juan Manuel ; FUERTES HUERTA, Ana ; LÓPEZ OGALLA, Javier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2017248556BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SÁNCHEZ-QUESADA, Jorge</creatorcontrib><creatorcontrib>MEDINA PADILLA, Miguel</creatorcontrib><creatorcontrib>DE CRISTOBAL BLANCO, Javier</creatorcontrib><creatorcontrib>PALOMO NICOLAU, Francisco</creatorcontrib><creatorcontrib>PÉREZ DE LA CRUZ MORENO, María Ángeles</creatorcontrib><creatorcontrib>MARTÍNEZ MONTERO, Olga</creatorcontrib><creatorcontrib>HERRERO SANTOS, Susana</creatorcontrib><creatorcontrib>RODRÍGUEZ SALGUERO, Beatriz</creatorcontrib><creatorcontrib>DOMÍNGUEZ CORREA, Juan Manuel</creatorcontrib><creatorcontrib>FUERTES HUERTA, Ana</creatorcontrib><creatorcontrib>LÓPEZ OGALLA, Javier</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SÁNCHEZ-QUESADA, Jorge</au><au>MEDINA PADILLA, Miguel</au><au>DE CRISTOBAL BLANCO, Javier</au><au>PALOMO NICOLAU, Francisco</au><au>PÉREZ DE LA CRUZ MORENO, María Ángeles</au><au>MARTÍNEZ MONTERO, Olga</au><au>HERRERO SANTOS, Susana</au><au>RODRÍGUEZ SALGUERO, Beatriz</au><au>DOMÍNGUEZ CORREA, Juan Manuel</au><au>FUERTES HUERTA, Ana</au><au>LÓPEZ OGALLA, Javier</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><date>2018-08-09</date><risdate>2018</risdate><abstract>The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2017248556BB2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A56%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=S%C3%81NCHEZ-QUESADA,%20Jorge&rft.date=2018-08-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2017248556BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true